A Study to assess the Safety, Tolerability and effect of RO7673396 when used alone as well as with other cancer medications in participants with Advanced Solid Tumors
YO45758
Phase 1 other active
Quick answer
A Study to assess the Safety, Tolerability and effect of RO7673396 when used alone as well as with other cancer medications in participants with Advanced Solid Tumors for Advanced Solid Tumors Harboring RAS Mutation(S) is a Phase 1 program (other) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Roche Registration Limited
- Indication
- Advanced Solid Tumors Harboring RAS Mutation(S)
- Phase
- Phase 1
- Modality
- other
- Status
- active